HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kim, Y I Articles by Dudek, F E Search for Related Content PubMed PubMed Citation Articles by Kim, Y I Articles by Dudek, F E

Mental Retardation Research Center, UCLA School of Medicine 90024.

1. To study the synaptic mechanisms of excitatory transmission in the suprachiasmatic nucleus (SCN), we assessed the effects of excitatory amino acid receptor antagonists on excitatory postsynaptic potentials (EPSPs) recorded from SCN neurons in horizontal and parasagittal hypothalamic slice preparations from rats and guinea-pigs. The EPSPs were evoked by electrical stimulation of either optic nerve or a site near the SCN. 2. When evoked at membrane potentials between -60 and -100 mV, the EPSPs from optic nerve stimulation were conventional in shape; they rose to the peak quickly (6.2 +/- 0.5 ms, mean +/- S.E.M.; n = 45) and decayed gradually over 50-250 ms. When evoked at membrane potentials between -20 and -55 mV after blockade of outward K+ currents and fast Na+ spikes by intracellular injection of Cs+ and QX-314 (n = 5 neurons), a slow depolarizing potential emerged near the fast peak of the EPSP. This slow potential, unlike the fast peak, was not linearly related to membrane potential. 3. An antagonist for kainate- and quisqualate-type excitatory amino acid receptors, 6,7-dinitroquinoxaline-2,3-dione (DNQX 1-10 microM), depressed in a concentration-dependent and reversible manner the EPSPs evoked by optic nerve stimulation at membrane potentials between -60 and -100 mV (n = 9). The effects of DNQX were not associated with any significant changes in the baseline input resistance or membrane potential of the postsynaptic neurons. The selective N-methyl-D-aspartate (NMDA) receptor antagonist, DL-2-amino-5-phosphonopentanoic acid (AP5, 50-100 microM), did not affect significantly and consistently the EPSPs evoked at these membrane potentials (n = 7). On the other hand, AP5 (50 microM) blocked or depressed the slow depolarizing component of the EPSPs evoked at membrane potentials between -20 and -55 mV (n = 4). No significant changes in baseline input resistance or membrane potential accompanied the effects of AP5. 4. Stimulation of a site lateral or dorsocaudal to the SCN evoked EPSPs distinct from those evoked by optic nerve stimulation. Again, DNQX (0.3-10 microM) depressed the EPSPs evoked at membrane potentials between -60 and -100 mV (n = 4) whereas AP5 (50 microM) had no effect (n = 5). When evoked at less negative membrane potentials (i.e. -20 to -55 mV) after intracellular injection of Cs+ and QX-314, the EPSPs had a slow depolarizing potential, similar to the EPSPs from optic nerve stimulation.(ABSTRACT TRUNCATED AT 400 WORDS)

This article has been cited by other articles:

				R. P. Irwin and C. N. Allen Calcium Response to Retinohypothalamic Tract Synaptic Transmission in Suprachiasmatic Nucleus Neurons J. Neurosci., October 24, 2007; 27(43): 11748 - 11757. [Abstract] [Full Text] [PDF]

				J. H. Meijer and W. J. Schwartz In Search of the Pathways for Light-Induced Pacemaker Resetting in the Suprachiasmatic Nucleus J Biol Rhythms, June 1, 2003; 18(3): 235 - 249. [Abstract] [PDF]

				S. Michel, J. Itri, and C. S. Colwell Excitatory Mechanisms in the Suprachiasmatic Nucleus: The Role of AMPA/KA Glutamate Receptors J Neurophysiol, August 1, 2002; 88(2): 817 - 828. [Abstract] [Full Text] [PDF]

				C. N. Allen, Z.-G. Jiang, K. Teshima, T. Darland, M. Ikeda, C. S. Nelson, D. I. Quigley, T. Yoshioka, R. G. Allen, M. A. Rea, et al. Orphanin-FQ/Nociceptin (OFQ/N) Modulates the Activity of Suprachiasmatic Nucleus Neurons J. Neurosci., March 15, 1999; 19(6): 2152 - 2160. [Abstract] [Full Text] [PDF]

				L. L. Haak Metabotropic Glutamate Receptor Modulation of Glutamate Responses in the Suprachiasmatic Nucleus J Neurophysiol, March 1, 1999; 81(3): 1308 - 1317. [Abstract] [Full Text] [PDF]

				G. Chen and A. N. van den Pol Coexpression of Multiple Metabotropic Glutamate Receptors in Axon Terminals of Single Suprachiasmatic Nucleus Neurons J Neurophysiol, October 1, 1998; 80(4): 1932 - 1938. [Abstract] [Full Text] [PDF]

				S. M. Biello, D. A. Golombek, K. M. Schak, and M. E. Harrington Circadian Phase Shifts to Neuropeptide Y In Vitro: Cellular Communication and Signal Transduction J. Neurosci., November 1, 1997; 17(21): 8468 - 8475. [Abstract] [Full Text] [PDF]

				G. Chen and A. N. van den Pol Multiple NPY Receptors Coexist in Pre- and Postsynaptic Sites: Inhibition of GABA Release in Isolated Self-Innervating SCN Neurons J. Neurosci., December 1, 1996; 16(23): 7711 - 7724. [Abstract] [Full Text] [PDF]

				A. N. van den Pol, K. Obrietan, G. Chen, and A. B. Belousov Neuropeptide Y-Mediated Long-Term Depression of Excitatory Activity in Suprachiasmatic Nucleus Neurons J. Neurosci., September 15, 1996; 16(18): 5883 - 5895. [Abstract] [Full Text] [PDF]

				C. F. Gillespie, K. L. Huhman, T. O. Babagbemi, and H. E. Albers Bicuculline Increases and Muscimol Reduces the Phase-Delaying Effects of Light and VIP/PHI/GRP in the Suprachiasmatic Region J Biol Rhythms, June 1, 1996; 11(2): 137 - 144. [Abstract] [PDF]

				J. Ding, D Chen, E. Weber, L. Faiman, M. Rea, and M. Gillette Resetting the biological clock: mediation of nocturnal circadian shifts by glutamate and NO Science, December 9, 1994; 266(5191): 1713 - 1717. [Abstract] [PDF]

				C. S. Colwell and M. Menaker NMDA as Well as Non-NMDA Receptor Antagonists Can Prevent the Phase-Shifting Effects of Light on the Circadian System of the Golden Hamster J Biol Rhythms, July 1, 1992; 7(2): 125 - 136. [Abstract] [PDF]